Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Ursodeoxycholic Acid, Silymarin, Antioxidants and Colchicine on Fibrosis Regression in HCV After Achieving Sustained Virological Response

NCT03659058 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.

NCT NCT03659058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03659058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Ursodeoxycholic Acid, Silymarin, Antioxidants and Colchicine on Fibrosis Regression in HCV After Achieving Sustained Virological Response
Lead sponsor
Zagazig University
Phase
Not applicable
Overall status
Completed
Start date
March 2, 2016
Completion date
August 1, 2018
Enrollment
400 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

fibrosis, liver